If you need more lookups,
subscriptions start at $34 USD/month.
Ron Lahav Location
Israel
Ron Lahav Work
CTO @ (October 2025 - Present)
Managing Director @ (August 2023 - Present)
Co-Founder @ (September 2018 - December 2023)
Executive Director Research and Development @ National Institute for Biotechnology in the Negev (NIBN) (September 2017 - December 2023)
CEO @ SpliSense (February 2017 - March 2018)
Chief Executive Officer @ ART BioScience Ltd (December 2015 - May 2017)
CEO and COO @ Quiet Therapeutics (May 2010 - November 2015)
Project Director @ Quark Pharmaceuticals (July 2007 - April 2010)
senior scientist @ (January 2005 - January 2007)
Postdoctoral fellow @ (January 2002 - January 2005)
Ron Lahav Education
Princeton University
Post Doctorate (Molecular Biology)
2002-2005
Ben Gurion University of the Negev
PhD (Environmental Microbiology)
1997-2002
Ron Lahav Skills
Molecular Biology
Animal Models
Therapeutics
Drug Discovery
Biotechnology
In Vivo
Pharmaceutical Industry
Lifesciences
Cancer
Drug Development
Biopharmaceuticals
Biochemistry
Early Stage Ventures
Leadership
Oral Communication
Ron Lahav Summary
Ron Lahav, based in Israel, is currently a CTO at ViVac Pharma. Ron Lahav brings experience from previous roles at NIBN | The National Institute for Biotechnology in the Negev, AltA-ZuZ Therapeutics, National Institute for Biotechnology in the Negev (NIBN) and SpliSense. Ron Lahav holds a 2002 - 2005 Post Doctorate in Molecular Biology @ Princeton University. With a robust skill set that includes Molecular Biology, Animal Models, Therapeutics, Drug Discovery, Biotechnology and more. Ron Lahav has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Ron Lahav?
Find contact details for 700 million professionals.